Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Timing your first automated investment depends on savings goals and risk comfort; starting early can compound gains over time with steady contributions.
15,330 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Evolution Petroleum Corp reaches a historic 50th consecutive quarterly dividend, delivering a 10.6% yield at a $4.50 ...
Two Kalshi veterans are raising up to $35 million for a new prediction-market VC fund called 5c(c) Capital, backed by...
Investors are weighing whether to buy Chewy stock before March 25. This guide breaks down the earnings setup, busines...
KB Home cuts its full-year outlook after flagging war-related demand weakness, warning that home says already hurting...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
IHS stock is up 57% as insiders trade. A CEO sale of 87,000 shares sparks questions about momentum and governance. Th...
Apple abandons the stalemate of building bigger AI models. In a bold pivot, the company opens iOS 27 to rival assista...
A new ETF focused on CTAs began trading this week, giving U.S. investors direct exposure to trend-following across mu...
In a markets backdrop marked by higher rates and sector stresses, SRET continues to pay monthly distributions, unders...
Timken stands at a pivotal moment as it reports Q1 2026 earnings. This guide breaks down the business mix, growth dri...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...